ArticleCell death & disease2021

Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells.

Tapas Patra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.